Araim Pharmaceuticals Inc - Company Review
SummaryAraim Pharmaceuticals Inc - Company Review
Summary
Araim Pharmaceuticals Inc (Araim), a subsidiary of Warren Pharmaceuticals Inc is a drug development company that discovers and develops novel treatments for devastating injuries and chronic diseases. The company discovers innate repair receptor, target for activating tissue repair, and recovery from inflammatory and other injuries. It offers ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, and anti-inflammatory signaling pathways through selective innate repair receptor activation. The company's therapeutic areas comprise neuropathy, cardiovascular injury, diabetes complications, wound healing, and other aging diseases, and treatment of painful small fiber neuropathy. Araim is headquartered in Tarrytown, New York, the US.
This comprehensive company report of Araim Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.